• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    3.87 Up 0.08(2.11%) 4:00PM EDT
    Add to Portfolio
    Prev Close:3.79
    Open:3.79
    Bid:3.70 x 3000
    Ask:3.99 x 800
    1y Target Est:8.07
    Beta:3.03
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:3.66 - 3.89
    52wk Range:3.66 - 12.39
    Volume:566,707
    Avg Vol (3m):633,254
    Market Cap:169.17M
    P/E (ttm):N/A
    EPS (ttm):-0.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 2.11%169.17M
    BAXDown 0.18%36.91B
    HSPUp 0.11%15.03B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback